Showing results (1-10 of 702) with videos related to
Sort By:
Pageof 71
Frontiers in Immunology|November 7, 2022
Antibody based conditioning for allogeneic hematopoietic stem cell transplantationAsim Saha, Bruce R BlazarBlood|August 29, 2009
Acute graft-versus-host disease: from the bench to the bedsideGerard Socié, Bruce R BlazarBlood|March 20, 2016
Preclinical models of acute and chronic graft-versus-host disease: how predictive are they for a successful clinical translation?Robert Zeiser, Bruce R BlazarFrontiers in Immunology|March 26, 2019
Achievement of Tolerance Induction to Prevent Acute Graft-vs.-Host DiseaseGovindarajan Thangavelu, Bruce R BlazarJournal of Leukocyte Biology|February 3, 2017
Role of myeloid-derived suppressor cells in allogeneic hematopoietic cell transplantationBrent H Koehn, Bruce R BlazarBlood Advances|August 16, 2018
How ibrutinib, a B-cell malignancy drug, became an FDA-approved second-line therapy for steroid-resistant chronic GVHDSamantha M Jaglowski, Bruce R BlazarPhilosophical Transactions of the Royal Society of London. Series B, Biological Sciences|September 9, 2005
Bone marrow transplantation and approaches to avoid graft-versus-host disease (GVHD)Bruce R Blazar, William J MurphyClinical Immunology (Orlando, Fla.)|August 17, 2021
ROCK2, a critical regulator of immune modulation and fibrosis has emerged as a therapeutic target in chronic graft-versus-host diseaseAlexandra Zanin-Zhorov, Bruce R BlazarSeminars in Immunology|February 7, 2006
Clinical application of expanded CD4+25+ cellsCarl H June, Bruce R BlazarBlood|February 14, 2018
B-cell targeting in chronic graft-versus-host diseaseRobert Zeiser, Stefanie Sarantopoulos, Bruce R BlazarPageof 71